Page 5 of 10 – SEC Filing CUSIP No. 451731103 13G Page 5 of 9 Pages
Explanatory Note: This Schedule 13G is being filed to report
that on April 29, 2016, the reporting persons’ beneficial ownership exceeded 5%. Subsequently, as a result of the
exercise of an underwriter’s option to purchase shares of the issuer’s common stock, such beneficial ownership
has decreased to below 5%.
Item 1. (a) Name of Issuer Ignyta, Inc. (b) Address of Issuer’s Principal Executive Offices 11111 Flintkote Avenue, San Diego, CA 92121 Item 2. (a) Name of Person Filing Great Point Partners, LLC Dr. Jeffrey R. Jay, M.D. Mr. David Kroin The Reporting Persons have entered into a Joint Filing Agreement, dated May 9, 2016, a copy of which is filed with this Schedule 13G as Exhibit A, pursuant to which the Reporting Persons have agreed to file this statement jointly in accordance with the provisions of Rule 13d-1(k)(1) under the Act. (b) Address of Principal Business Office, or if none, Residence The address of the principal business office of each of the
Reporting Persons is 165 Mason Street, 3rd Floor Greenwich, CT 06830 (c) Citizenship Great Point Partners, LLC is a limited liability company organized under the laws of the State of Delaware. Dr. Jeffrey R. Jay, M.D. is a citizen of the United States. Mr. David Kroin is a citizen of the United States. (d) Title of Class of Securities Common Stock (e) CUSIP Number 451731103 Item 3. If this statement is filed pursuant to §240.13d-1(b) or 240.13d.2(b) or (c), check whether the person
filing is a: Not Applicable. (a) o Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o) (b) o Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c). (c) o Insurance company as defined in Section 3(a)(19) of the Act (15. U.S.C. 78c). (d) o Investment Company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
(e) o An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E).
| CUSIP No. 451731103 | 13G | Page 5 of 9 Pages |
Explanatory Note: This Schedule 13G is being filed to report
that on April 29, 2016, the reporting persons’ beneficial ownership exceeded 5%. Subsequently, as a result of the
exercise of an underwriter’s option to purchase shares of the issuer’s common stock, such beneficial ownership
has decreased to below 5%.
| Item 1. | |||
| (a) | Name of Issuer | ||
| Ignyta, Inc. | |||
| (b) | Address of Issuer’s Principal Executive Offices | ||
| 11111 Flintkote Avenue, San Diego, CA 92121 | |||
| Item 2. | |||
| (a) | Name of Person Filing | ||
| Great Point Partners, LLC | |||
| Dr. Jeffrey R. Jay, M.D. | |||
| Mr. David Kroin | |||
| The Reporting Persons have entered into a Joint Filing Agreement, dated May 9, 2016, a copy of which is filed with this Schedule 13G as Exhibit A, pursuant to which the Reporting Persons have agreed to file this statement jointly in accordance with the provisions of Rule 13d-1(k)(1) under the Act. | |||
| (b) | Address of Principal Business Office, or if none, Residence | ||
| The address of the principal business office of each of the Reporting Persons is | |||
| 165 Mason Street, 3rd Floor | |||
| Greenwich, CT 06830 | |||
| (c) | Citizenship | ||
| Great Point Partners, LLC is a limited liability company organized under the laws of the State of Delaware. Dr. Jeffrey R. Jay, M.D. is a citizen of the United States. Mr. David Kroin is a citizen of the United States. | |||
| (d) | Title of Class of Securities | ||
| Common Stock | |||
| (e) | CUSIP Number | ||
| 451731103 | |||
| Item 3. | If this statement is filed pursuant to §240.13d-1(b) or 240.13d.2(b) or (c), check whether the person filing is a: | ||
| Not Applicable. | |||
| (a) | o | Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o) | |
| (b) | o | Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c). | |
| (c) | o | Insurance company as defined in Section 3(a)(19) of the Act (15. U.S.C. 78c). | |
| (d) | o | Investment Company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8). | |
| (e) | o | An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E). | |
Follow Ignyta Inc. (NASDAQ:RXDX)
Follow Ignyta Inc. (NASDAQ:RXDX)
We may use your email to send marketing emails about our services. Click here to read our privacy policy.
